Effect of hyperosmotic mannitol on myocardial oxygen consumption.
Hyperosmotic mannitol produces salutary hemodynamic and histologic effects during experimental myocardial ischemia. However, the administration of hyperosmotic mannitol is associated with a positive inotropic influence. Positive inotropic interventions, which increase myocardial oxygen consumption (MVO2), also tend to increase the extent of ischemic myocardial injury. Thus, the purpose of this study was to determine the effect of mannitol on MVO2. Anesthetized dogs on right-heart bypass under conditions of controlled hemodynamics were studied. Both coronary arteries were perfused; mannitol was infused via the coronary perfusion cannulas to produce a 35 mosmol increase in osmolality. Heart rate was maintained constant. Cardiac output was held constant or deliberately increased so that left ventricular end-diastolic pressure and tension-time index, two other hemodynamic correlates of MVO2, remained constant or increased. MVO2 significantly decreased under conditions of decreased myocardial perfusion (P less than 0.025). This was in spite of a significant increase (P less than 0.001) in the peak rate of rise of left ventricular pressure (LV dP/dt), a hemodynamic correlate of MVO2. Thus, hyperosmotic mannitol under conditions of reduced coronary perfusion increases myocardial efficiency.
D000818:Animals; D001794:Blood Pressure; D002302:Cardiac Output; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000378:metabolism; D003331:Coronary Vessels; D004285:Dogs; D005260:Female; D006321:Heart / Q000502:physiology; D006339:Heart Rate; D006982:Hypertonic Solutions; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008353:Mannitol / Q000494:pharmacology*; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects*; D012039:Regional Blood Flow; D013268:Stimulation, Chemical
D006982:Hypertonic Solutions; D008353:Mannitol; D007545:Isoproterenol